|1.||Saeki, Keigo: 2 articles (05/2015 - 01/2014)|
|2.||Obayashi, Kenji: 2 articles (05/2015 - 01/2014)|
|3.||Kurumatani, Norio: 2 articles (05/2015 - 01/2014)|
|4.||Tomioka, Kimiko: 2 articles (05/2015 - 01/2014)|
|5.||Bolt, Hermann M: 2 articles (07/2013 - 02/2004)|
|6.||Vermeulen, Roel: 2 articles (12/2012 - 08/2012)|
|7.||Golka, Klaus: 2 articles (01/2012 - 02/2004)|
|8.||Okamoto, Nozomi: 1 article (05/2015)|
|9.||Tanaka, Yuu: 1 article (01/2014)|
|10.||Schlüter, Gerhard: 1 article (07/2013)|
|1.||Urinary Bladder Neoplasms (Bladder Cancer)
02/01/2003 - "The Drake Health Registry Study (DHRS) is an ongoing bladder cancer screening program initiated in 1986 due to workers' probable past exposure to the bladder carcinogen, beta-naphthylamine (BNA). "
11/01/1998 - "The National Institute for Occupational Safety and Health (NIOSH) has previously conducted studies of bladder cancer incidence and mortality at a synthetic dye plant that manufactured beta-naphthylamine from 1940 through 1979. "
09/01/1990 - "In 1986, the Drake Health Registry Study initiated bladder cancer screening for 366 persons at high risk because of occupational exposure to beta-naphthylamine. "
07/01/2013 - "Technical-grade P2NA was contaminated with carcinogenic 2-naphthylamine (2NA), and bladder cancer risk in exposed workers was attributed to this impurity. "
01/01/2012 - "Hueper was the first to induce bladder cancer in animal experiments, applying beta-naphthylamine to dogs. "
|2.||Urologic Diseases (Urinary Tract Disease)
07/01/1991 - "No urothelial tumor occurred in the workers exposed to beta-naphthylamine. "
12/01/1989 - "The incidence of such malignant tumors was significantly higher in the workers who had been exposed to 2-naphthylamine than in others. "
12/01/1981 - "However, 2-naphthylamine and two of the three sulfonic acid derivatives of 2-naphthylamine tested produced statistically significant lung tumor responses at comparable doses. "
01/01/1981 - "The carcinogen, 2-naphthylamine (2-NA), induces tumor formation in the urinary bladder but not the liver of several species, including humans and dogs. "
09/01/1980 - "It is likely that there has been an increased risk of cancer since the elimination of alpha- and beta-naphthylamine by 1950. "
02/01/1978 - "Of the dogs given the same dose of 2-naphthylamine for 26 weeks and then kept for 3 years before being killed, 2 dogs had normal bladders but the other 2 had epithelial carcinomas."
01/01/1973 - "[Experimental induction of bladder carcinoma through the administration of beta-naphthylamine]."
12/01/1989 - "Occupational urothelial carcinomas which were developed by benzidine and beta-naphthylamine have been diagnosed and treated in 60 workers. "
12/01/1981 - "Two of 8 dogs receiving 6% 2-naphthylamine in 1-naphthylamine developed early carcinoma and 2/8 dogs receiving 0.5% 2-naphthylamine in 1-naphthylamine developed haemangioma of the bladder. "
10/01/1979 - "Oral administration of 2-naphthylamine for 40 weeks plus injections of cyclophosphamide produced bladder carcinomas in 30.8 approximately 35.7% of all animals, associated with downward growth of the bladder epithelium. "
|5.||Transitional Cell Carcinoma
12/01/1981 - "All dogs which received pure 2-naphthylamine developed transitional-cell carcinomas of the bladder within 34 months. "
05/01/1969 - "Induction of transitional cell carcinomas of the urinary bladder in monkeys fed 2-naphthylamine."
12/01/1997 - "Epidemiologic studies have revealed an increased risk for development of transitional cell carcinoma (TCC) among dye workers/painters occupationally exposed to aromatic amines such as benzidine, beta-naphthylamine, orthotoluidine, and aniline. "
|2.||1-Naphthylamine (1 Naphthylamine)
|8.||aniline (aniline hydrobromide)
|9.||Vinyl Chloride (Chloroethylene)